Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13)

Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023

Mohammadreza Malek Zadeh

• View Article